Virax Biolabs Group Limited (VRAX) has 12 identified peers for comparison in the Healthcare sector. Peers include ALLR, BDRX, BWV, CDIO, HILS, KPRX and others.
VRAX has a market capitalization of $650.43K, compared to an average peer market cap of $18.18M. VRAX is notably smaller than its average peer.